Arena Pharmaceuticals, Inc.

Headquarters: San Diego, CA, United States

Founded: 1997

Employees: 448

CEO: Mr. Amit D. Munshi M.B.A.


Market Cap

$6.17 Billion

USD as of March 1, 2022

history Market Cap History

Arena Pharmaceuticals, Inc. market capitalization over time

Evolution of Arena Pharmaceuticals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Arena Pharmaceuticals, Inc.

Detailed Description

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

Top 1-year algo backtest: +240.10%

$10,000 in February 2023 would now be $34,010 by following it 5 minutes per day at market close.

How much did you gain in the last 12 months?

Stocks & Indices

Arena Pharmaceuticals, Inc. has the following listings and related stock indices.

Stock: NASDAQ: ARNA wb_incandescent

Stock: FSX: RN3N wb_incandescent

Product & Services


Key People

Jack Lief, co-founder Dominic Behan, co-founder and senior scientist Amit Munshi, CEO Kevin Lind, CFO


Revenue: US$27,600,000 (FY 2012)

Operating income: US$−57,000,000 (FY 2012)

Net income: US$−85,500,000 (FY 2012)

Total assets: US$261,000,000 (FY 2012)

Total equity: US$98,600,000 (FY 2012)



6154 Nancy Ridge Drive

San Diego, CA 92121

United States

Phone: 858 453 7200